Doctors accusing a drug company of violating a consumer harassment law by faxing invitations to a free dinner seminar on a sexual disorder—while the company was seeking approval of a drug to treat it—have had their case resurrected.
The doctors claim Boehringer Ingelheim Pharmaceuticals violated the federal Telephone Consumer Protection Act of 1991 (TCPA) by sending unsolicited faxes for a dinner talk on female sexual dysfunction and hypoactive sexual desire disorder.